Hepatitis C Virus Therapy
Research from Walter Reed Army Medical Center yields new data on hepatitis C virus therapy
Published in Hepatitis Weekly, July 16th, 2007
A report, "Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin," is newly published data in Digestive Diseases and Sciences. According to recent research from the United States, "Achieving an antiviral response at a reasonable cost is a challenge in the treatment of patients with chronic hepatitis C. A previous study indicated that consensus interferon with ribavirin had promising activity against hepatitis C virus (HCV) genotype 1."
"The objective of this study was to determine the virologic response with consensus interferon or pegylated interferon alpha-2b plus weight-ribavirin in patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-07-16)
More Articles from Hepatitis Weekly
- Hepatitis C Virus
Numerous factors affect success of interferon treatment for hepatitis C - Hepatitis C Virus
Peregrine Pharmaceuticals Announces Registered Direct Offering of $22.5 Million in Common Stock - Hepatitis C Virus
SciClone Initiates Phase 2 Clinical Trial Using SCV-07 to Treat Hepatitis C Patients - Hemophilia Risk Factors
Study results from National Institutes of Health provide new insights into hemophilia risk factors - Hepatitic B Vaccines
Studies from University of Alberta, Department of Medicine yield new information about hepatitic b vaccines - Hepatitis B Virus
Reports from Sun Yat-Sen University highlight recent research in hepatitis B virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
